Posted by Michael Wonder on 26 Jun 2024
Tofidence (tocilizumab), a biosimilar referencing RoActemra, approved in the European Union
24 June 2024 - Tofidence complements existing portfolio of immunology biosimilars commercialised by Biogen
Biogen announced that the European Commission has granted approval for Tofidence, a biosimilar monoclonal antibody referencing RoActemra.
